Got 90 Seconds? Then listen to TruScreen CEO Martin Dillon talk about the company’s recent success and potential transition onto the ASX.
Listed on the New Zealand Stock Exchange (NZX), TruScreen Limited (NZX:TRU) is a medtech company focused on the development and sale of devices that provide real-time screening of cervical cancer.
The company has announced some key business milestones in the last few months, including a planned expansion in East Africa, a new distributor in Russia and a potential move from the NZX to the ASX.
The full article can be read here.